AMPK and Cancer
This chapter focuses on the role of AMPK as a stress-response molecule with an emphasis on its duplex implication in carcinogenesis and cancer drug resistance. AMPK is closely correlated to the tumor-suppressive functions of LKB1 and P53, consequently modulating the activity of cellular survival signaling such as mTOR and Akt, leading to cell growth inhibition and cell cycle arrest. On the contrary, AMPK is tightly involved in cancer drug resistance via interacting with multiple known mechanisms of chemoresistance such as ABCG2 expression, autophagy induction, and cancer stem cells enrichment. Targeting AMPK has become a novel strategy for cancer prevention and treatment.
KeywordsAMPK Carcinogenesis Cancer drug resistance Stress-response Cancer prevetion
Conflict of Interests
No potential conflicts of interest exist.
Acknowledgements This work was supported by the National Natural Science Foundation of China (81402173 and 81573651) and Pearl River S&T Nova Program of Guangzhou (201506010098).
- Chang Z, Huo L, Li K, Wu Y, Hu Z (2014) Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro. Sci World J 2014:794756Google Scholar
- Corominas-Faja B, Cufí S, Oliveras-Ferraros C et al (2013) Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway. Cell Cycle 12:3109–3124PubMedPubMedCentralCrossRefGoogle Scholar
- Ferlay J, Soerjomataram I, Ervik M, et al (2012) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from http://globocan.iarc.fr
- Hardie DG (2014) AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol 33C:1–7Google Scholar